IP Library Assignment 040364/0118
Patent Assignment
Reel/Frame 040364/0118

Assignment of Assignor's Interest

Recorded: 2016-11-17 Pages: 9
Assignors
AKIREDDY, SRINIVASA RAO
Executed: 2011-05-16
BHATTI, BALWINDER SINGH
Executed: 2011-05-18
CUTHBERTSON, TIMOTHY J.
Executed: 2011-05-16
DULL, GARY MAURICE
Executed: 2011-05-16
MILLER, CRAIG HARRISON
Executed: 2011-06-02
MITCHENER, JOSEPH PIKE, JR.
Executed: 2011-05-16
MUNOZ, JULIO A.
Executed: 2011-05-26
OTTEN, PIETER ALBERT
Executed: 2011-05-18
Assignee
TARGACEPT, INC.
200 EAST FIRST STREET, SUITE 300, WINSTON-SALEM, NORTH CAROLINA, 27101
Covered Property (1)
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Patent: 9,981,949 →
Application: 15/354,832 →
Publication: US 2017/0260167
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Nov 17, 2016
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 040645/0359 →
Assignment of Assignor's Interest Nov 17, 2016
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 040645/0282 →
Change of Name Jan 13, 2017
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 041044/0211 →
Assignment of Assignor's Interest Jan 13, 2017
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 041043/0769 →
Patent Security Agreement Aug 5, 2021
From: OYSTER POINT PHARMA, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057104/0189 →
Corrective Assignment to Correct the the Conveying Party Execution Date Previously Recorded at Reel: 041044 Frame: 0211. Assignor(S) Hereby Confirms the Assignment. Oct 26, 2021
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 057923/0518 →
Release of Security Interest Feb 3, 2023
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: OYSTER POINT PHARMA INC.
Reel/Frame 062582/0873 →